Cyclic implant perfusion, cleaning and passivation process and implant produced thereby
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61N-001/02
A01N-001/02
A61L-002/00
A61L-002/025
출원번호
US-0203925
(2014-03-11)
등록번호
US-9332750
(2016-05-10)
발명자
/ 주소
Mills, C. Randal
Wironen, John F.
Hanstke, Sean
출원인 / 주소
RTI Surgical, Inc.
대리인 / 주소
McAndrews, Held & Malloy, Ltd.
인용정보
피인용 횟수 :
3인용 특허 :
82
초록▼
This invention is a novel method for perfusion of a porous implant which achieves efficient interpenetration of desired factors into and removal of undesirable factors from the pores of the implant, cleaning of the implant, efficient passivation of the implant (inactivation of pathogens, microorgani
This invention is a novel method for perfusion of a porous implant which achieves efficient interpenetration of desired factors into and removal of undesirable factors from the pores of the implant, cleaning of the implant, efficient passivation of the implant (inactivation of pathogens, microorganisms, cells, viruses and the like and reduction in antigenicity thereof), and the novel implant produced by such treatment. The process presents a system wherein the rate of pressure cycling, the fact of pressure cycling, and the amplitude of pressure cycling, results in highly cleaned tissues and other implants for implantation. Target decontamination goals for this process include between about a one (1) to twelve (12) log reduction in bacterial contamination, between about a one (1) to fifteen (15) log reduction in enveloped virus contamination, up to about a five (5) log reduction in non-enveloped virus contamination, between about a two (2) to ten (10) fold reduction in endotoxin, maintenance of implant or graft biologic and biomechanical properties, absence of tissue toxicity due to cleaning solutions used, and reduced implant antigenicity.
대표청구항▼
1. A method for producing a cleaned allograft or xenograft tissue implant by perfusion of cleaning solutions comprising: machine dimensioning an allograft or xenograft tissue implant to achieve final implant dimensions;placing said implant in a sealed vessel; andexposing said implant to three or mor
1. A method for producing a cleaned allograft or xenograft tissue implant by perfusion of cleaning solutions comprising: machine dimensioning an allograft or xenograft tissue implant to achieve final implant dimensions;placing said implant in a sealed vessel; andexposing said implant to three or more different cleaning solutions in series;wherein said three or more different cleaning solutions comprise, respectively:a) a detergent solution; b) a water-miscible alcohol; and c) a hydrogen peroxide solution; and further wherein oscillating fluid pressure is used during at least a part of said exposing step. 2. The method of claim 1, wherein the implant produced is suitable for implantation or processing for implantation in humans. 3. The method of claim 1, wherein said tissue comprises at least one of the following: cortical bone, cancellous bone, fascia, whole joint, tendon, ligament, dura, pericardia, heart valve, vein, neural tissue, submucosal tissue, cartilage, or combinations thereof. 4. The method of claim 3, wherein said tissue comprises at least one of the following: cortical bone or cancellous bone, or combinations thereof. 5. The method of claim 3, wherein said tissue comprises at least one of the following: fascia, whole joint, tendon, ligament, dura, pericardia, heart valve, vein, neural tissue, submucosal tissue, or cartilage, or combinations thereof. 6. The method of claim 1, wherein said implant is made from tissue derived from a single donor. 7. The method of claim 1, wherein said implant is made from tissue derived from a pool of donor tissues. 8. The method of claim 1, further comprising placing said cleaned tissue implant into a sterile, sealable package. 9. The method of claim 8, further comprising performing a surface decontamination step prior to sealing said package. 10. The method of claim 1, wherein the implant is perfused or coated with a bioactive substance. 11. The method of claim 10, wherein said bioactive substance is a drug or a growth factor. 12. The method of claim 11, wherein said growth factor is a bone morphogenetic protein, tissue growth factor beta or a member of the tissue growth factor beta family of growth factors, cartilage-derived morphogenetic proteins I or II or both, a cartilage derived growth factor, an angiogenic factor, or platelet derived growth factor. 13. The method of claim 1, further comprising maintaining the temperature between about 35-40 degrees centigrade during the exposing step.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (82)
Kevin R. Stone, Anterior cruciate ligament xenografts.
Brendel Klaus (Tucson AZ) Duhamel Raymond C. (Tucson AZ), Body implants of extracellular matrix and means and methods of making and using such implants.
Abraham Ginger A. ; Carr ; Jr. Robert M. ; Kemp Paul D.,GBX ; Mercer Ryan ; Baker Linda, Chemical treatment, without detergents or enzymes, of tissue to form an acellular, collagenous matrix.
Young Jack H. (Crawford PA) Karle David A. (Erie PA) Halleck Frank E. (Erie PA), Combined ultrasonic cleaning and biocidal treatment in a single pressure vessel.
Badylak Stephen F. (W. Lafayette IN) Geddes Leslie A. (W. Lafayette IN) Shelbourne K. Donald (Indianapolis IN) Lantz Gary C. (Lafayette IN) Coffey Arthur C. (Indianapolis IN), Graft for promoting autogenous tissue growth.
Ulrich Heinrich (Galgenbergweg 28 D 89077 Ulm/Donau DEX) Wolf Oleg J. P. (Berlin DEX), Implant for the replacement of vertebrae and/or stabilization and fixing of the spinal column.
Coles John G.,CAX ITX M4R 1M4 ; Takahashi Miyoko,CAX ITX M2N 1B8 ; Young David S. F.,CAX ITX M5T 1L1 ; Brockhausen Inka,CAX ITX M1N 2T4, Inhibition of human xenogenic or allogenic antibodies to reduce xenograft or allograft rejection in human recipients.
Black Jonathan (King of Prussia PA) Manley Michael T. (Franklin Lakes NJ) Serekian Paul (Mahwah NJ), Interlocking structural elements and method for bone repair, augmentation and replacement.
Trml Pertti (Reikonkatu 7 C 7 SF-33730 Tampere FIX) Vainionp Seppo (Orapihlajatie 21-27 B 12 SF-00320 Helsinki FIX) Rokkanen Pentti (Marjaniemenranta 29 SF-00930 Helsinki FIX) Helevirta Pertti (Ojava, Layered surgical biocomposite material.
Celeste Anthony J. (Hudson MA) Wozney John M. (Hudson MA) Rosen Vicki A. (Brookline MA) Wolfman Neil M. (Dover MA) Thomsen Gerald H. (Port Jefferson NY) Melton Douglas A. (Lexington MA), Methods of inducting formation of tendon and/or ligament tissue comprising administering BMP-12, BMP-13, and/or MP-52.
Scarborough Nelson L. ; Morris John W. ; Russell James L. ; Dowd Michael, Pressure flow system and method for treating a fluid permeable workpiece such as a bone.
Wolfinbarger ; Jr. Lloyd, Process and composition for cleaning soft tissue grafts optionally attached to bone and soft tissue and bone grafts produced thereby.
Fages Jacques,FRX ; Marty Alain,FRX ; Combes Didier,FRX ; Condoret Jean-Stephane,FRX, Process for treating bone tissue and corresponding implantable biomaterials.
Jackson David P. (22328 W. Barcotta Dr. Santa Clarita CA 91350) Lepp Michael A. (22334 W. Barcotta Dr. Santa Clarita CA 91350), Processes for cleaning, sterilizing, and implanting materials using high energy dense fluids.
Shimp, Lawrence A.; Winterbottom, John M.; Kaes, David R.; Boyce, Todd M.; Martz, Erik O., Spinal intervertebral implant, interconnections for such implant and processes for making.
Phillips Richard E. (San Marcos TX) Moore Mark A. (Austin TX) Russell Ruth L. (Long Beach CA) Cheung David (Arcadia CA), Sterilization of tissue implants using iodine.
Tucker Marjorie M. (Holliston MA) Rueger David C. (Southborough MA) Sampath Kuber T. (Holliston MA), Terminally sterilized osteogenic devices and preparation thereof.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.